PACKAGE LEAFLET: INFORMATION FOR THE USER. TRAVATAN 40 micrograms/ml eye drops, solution Travoprost

Similar documents
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TRAVATAN Z Travoprost Ophthalmic Solution

Package leaflet: Information for the user. Fredomat 40 microgram/ml oogdruppels, oplossing. Travoprost

Package Leaflet Information for the User ILUBE 5% w/v eye drops, solution. Acetylcysteine

Package leaflet: Information for the user. Travoprost Pharmathen 40 microgram/ml, oogdruppels, oplossing Travoprost

Package leaflet: Information for the patient SAFLUTAN 15 micrograms/ml Eye drops, solution in single dose-container. Tafluprost

PACKAGE LEAFLET: INFORMATION FOR THE USER. Clindamycin 300 mg Capsules Clindamycin (as hydrochloride)

Daktacort 2% / 1% w/w cream

Eumovate Cream clobetasone butyrate

Dermovate Scalp Application clobetasol propionate

Dermovate Scalp Application clobetasol propionate

Eumovate Ointment clobetasone butyrate

Dermovate Ointment clobetasol propionate

Betnovate Scalp Application betamethasone valerate. 1 What Betnovate is and what it is used for. 2 What you need to know before you use Betnovate

ClobaDerm 0.05% w/w Cream & Ointment (clobetasol propionate)

PATIENT INFORMATION LEAFLET. Alphaderm 1% & 10% w/w Cream hydrocortisone and urea

What is in this leaflet 1. What Dalacin Cream is and what it is used for

Package Leaflet: Information for the User

Package leaflet: Information for the user. Versatis 700 mg medicated plaster Lidocaine

Dermovate Ointment clobetasol propionate

ClobaDerm 500 micrograms/g Cream & Ointment (clobetasol propionate)

Package leaflet: Information for the user. Tactuo 0.1% / 2.5% gel Adapalene/Benzoyl Peroxide

PACKAGE LEAFLET: INFORMATION FOR THE USER. Schollmed Once Weekly Fungal Nail Treatment 5% w/v Medicated Nail Lacquer

Package leaflet: Information for the user. Trimovate Cream clobetasone 17-butyrate, calcium oxytetracycline and nystatin

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 5 g and pre-medication packs) lidocaine 2.5%, prilocaine 2.5%

1 What Gyno-Daktarin cream is and what it is used for

Package leaflet: Information for the user Rogaine 50 mg/g, cutaneous foam. minoxidil

PACKAGE LEAFLET: INFORMATION FOR THE USER. Isotrex Gel isotretinoin 0.05% w/w

Package leaflet: Information for the user. ZORAC 0.05% gel ZORAC 0.1% gel. Tazarotene

Occlusal 26%w/w cutaneous solution salicylic acid

Package leaflet: Information for the user. Vaniqa 11.5% cream Eflornithine

Package leaflet: Information for the patient. Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide

Rheumon Gel 1 g of gel contains 50 mg of etofenamate. For use in adults.

PATIENT INFORMATION LEAFLET. Timodine Cream

Package leaflet: Information for the patient. Duac Once Daily 10mg/g + 50mg/g Gel clindamycin + anhydrous benzoyl peroxide

Package leaflet: Information for the user. Regaine for Men Extra Strength Scalp Foam 5% w/w cutaneous foam. Minoxidil

PATIENT INFORMATION LEAFLET. Hydromol HC Intensive Hydrocortisone and urea

PACKAGE LEAFLET: INFORMATION FOR THE USER. Vaniqa 11.5% cream Eflornithine

DUAL ACTION LOGO. Quinoderm 10% / 0.5% w/w Cream Benzoyl Peroxide, hydrous / Potassium Hydroxyquinoline Sulfate

Package leaflet: Information for the patient. Onytec 80 mg/g medicated nail lacquer For adults Ciclopirox

Dalacin V Cream Clindamycin phosphate

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

Retin-A 0.05% w/w cream

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5%

PENTAMYCETIN is an antibiotic that: Stops the growth of bacteria Kills bacteria

scalp solution 5% w/v minoxidil cutaneous solution to be applied to the scalp

Hair Loss Treatment Regular Strength (Minoxidil)

v02 USER INFORMATION LEAFLET 5% w/v Cutaneous Solution Minoxidil for MEN AND WOMEN 139.7mm 69.85mm 69.85mm 130.2mm Inside Cover CELL SIZE 1mm

2% w/v Cutaneous Solution Minoxidil PATIENT INFORMATION LEAFLET PANTONE 185 C. 120lpi 0degrees. Black 120lpi 0degrees. Varnish 120lpi 0degrees

Package leaflet: Information for the user. Acnatac 10 mg/g mg/g gel clindamycin and tretinoin

DP Fusidic Acid Cream

PATIENT INFORMATION LEAFLET. AMETOP GEL 4% w/w Tetracaine

O N C E A DAY. In this leaflet FOR WOMEN

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and clotrimazole 1% w/w

Package leaflet: Information for the user EMLA Cream 5% (for 30 g surgical packs) lidocaine/prilocaine

Package leaflet: Information for the patient. Clindamycin ABR 150 mg capsules, hard. Clindamycin ABR 300 mg capsules, hard

EMLA. Prilocaine 2.5%, Lignocaine 2.5% CONSUMER MEDICINE INFORMATION

ISOTREX GEL Isotretinoin 0.05% w/w

PACKAGE LEAFLET. EN Elastoplast Heat Plaster 11 mg January

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

ACETOCAUSTIN 0,5 ml, Cutaneous solution

COLORADO AESTHETIC CENTER

A guide for patients who have been prescribed Stelara

Hydroform Cream 1% Hydrocortisone (microfine) 1% w/w and clioquinol 1% w/ w

Consumer Medicine Information. Topical Cream Clotrimazole 10 mg/g & Hydrocortisone 10 mg/g

PATIENT INFORMATION LEAFLET PUVA TREATMENT. using. Puvasoralen 1.2% Bath Lotion (8-methoxypsoralen)

CONSUMER MEDICINE INFORMATION

Daivobet 50/500 gel Dye-vo-bet

WOMEN'S Regaine EXTRA STRENGTH

MyStelara. For patients who have been prescribed Stelara

EUMOVATE Clobetasone butyrate 0.05% w/w cream

SIGMACORT cream and ointment

Psoralen Tablets (Methoxypsoralen)

Patient Information Leaflet. Dermal Filler

v MM 130.2MM FOR WOME N O N C E A D AY

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

PHARMACY PRACTICE I LAB PHCY 280L

Information PROPECIA Finasteride 1mg Tablet

clindamycin (as phosphate) 1% w/w and tretinoin 0.025% w/w; (klin-da-mye-sin fos-fate) and (tret- i-noin) CONSUMER MEDICINE INFORMATION

STELARA INJECTION Ustekinumab (rmc) Consumer Medicine Information

ARE YOU? PsA TREAT YOUR SYMPTOMS WITH FOUR DOSES A YEAR. RECOGNIZE THE FOUR SIGNS OF PsA.

For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory OILATUM EMOLLIENT. Light Liquid Paraffin Emollient

FACT SHEET: ISOTRETINOIN INFORMATION FOR PATIENTS

Cosmetic Surgery: Eyelid Surgery (Blepharoplasty)

Administering ORENCIA (abatacept): Your Step-by-Step Guide

Pre Treatment Advice and Procedures

FREQUENT REPLACEMENT CONTACT LENS. A Guide to Trouble-Free Contact Lens Wear (Instructions for Use)

Why should you self-care? How can my local pharmacist help? How your pharmacist can help

POLYTAR Plus Liquid PRODUCT INFORMATION. Polytar Plus Liquid medicated scalp cleanser, contains coal tar solution.

Ego DermAid 1% cream Hydrocortisone 1 % w/w

EVERYONE WILL NOTICE. No One Will Know.

Skin Allergy Testing Information

SELECT 1 DAY CONTACT LENS

When your eyes feel dry, burning or itchy, there s a range of solutions:

Information for Patients with Dry Eye

Safety Data Sheet. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

Brow and Beauty Bar - Permanent Makeup

NEWS RELEASE. CONTACTS: Investors: Lisa DeFrancesco (862) Media: Mark Marmur (862) Ember Garrett (714)

Skin Care During Radiation Therapy

Atopic Dermatitis (Eczema) Allergy and Immunology Awareness Program

Health Questionnaire

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER TRAVATAN 40 micrograms/ml eye drops, solution Travoprost Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet, See section 4. What is in this leaflet 1 What TRAVATAN is and what it is used for 2. What you need to know before you use TRAVATAN 3. How to use TRAVATAN 4. Possible side effects 5. How to store TRAVATAN 6. Contents of the pack and other information 1. What TRAVATAN is and what it is used for TRAVATAN contains travoprost, one of a group of medicines called prostaglandin analogues. It works by reducing the pressure in the eye. It may be used on its own or with other drops e.g. beta-blockers, which also reduce pressure. TRAVATAN is used to reduce high pressure in the eye in adults, adolescents and children from 2 months old onward. This pressure can lead to an illness called glaucoma. 2. What you need to know before you use TRAVATAN Do not use TRAVATAN If you are allergic to travoprost or any of the other ingredients of this medicine (listed in section 6). Ask your doctor for advice if this applies to you. Warning and Precautions TRAVATAN may increase the length, thickness, colour and/or number of your eyelashes. Changes in the eyelids including unusual hair growth or in the tissues around the eye have also been observed. TRAVATAN may change the colour of your iris (the coloured part of your eye). This change may be permanent. A change in the colour of the skin around the eye may also occur. If you have had cataract surgery, talk to your doctor before you use TRAVATAN. 1

If you have current or previous history of an eye inflammation (iritis and uveitis), talk to your doctor before you use TRAVATAN. TRAVATAN may rarely cause breathlessness or wheezing or increase the symptoms of asthma. If you are concerned about changes in your breathing pattern when using TRAVATAN advise your doctor as soon as possible. Travoprost may be absorbed through the skin. If any of the medicinal product comes into contact with the skin, it should be washed off straight away. This is especially important in women who are pregnant or are attempting to become pregnant. If you wear soft contact lenses, do not use the drops with your lenses in. After using the drops wait 15 minutes before putting your lenses back in. Children and adolescents TRAVATAN can be used in children from 2 months to < 18 years at the same dose as for adults. Use of TRAVATAN is not recommended to those children under 2 months of age. Other medicines and TRAVATAN Tell your doctor or pharmacist if you are taking or have recently taken or used any other medicines. Pregnancy, breast feeding and fertility Do not use TRAVATAN if you are pregnant. If you think that you may be pregnant speak with your doctor right away. If you could become pregnant you must use adequate contraception whilst you use TRAVATAN. Do not use TRAVATAN if you are breast feeding. TRAVATAN may get into your milk. Ask your doctor for advice before taking any medicine. Driving and using machines You may find that your vision is blurred for a time just after you use TRAVATAN. Do not drive or use machines until this has worn off. TRAVATAN contains hydrogenated castor oil and propylene glycol which may cause skin reactions and irritation. 3. How to use TRAVATAN Always use this medicine exactly as your doctor or the doctor treating your child has told you. You should check with your doctor, the doctor treating your child or pharmacist if you are not sure. The recommended dose is One drop in the affected eye or eyes, once a day - in the evening. Only use TRAVATAN in both eyes if your doctor told you to. Use it for as long as your doctor or the doctor treating your child told you to. Only use TRAVATAN for dropping in your or your child s eye(s). 2

1 2 3 4 Immediately before using a bottle for the first time, tear open the overwrap pouch, take the bottle out (picture 1) and write the date of opening on the carton in the space provided Wash your hands Twist off the cap Hold the bottle, pointing down, between your thumb and fingers Tilt your head or your child s head gently back. Pull down the eyelid with a clean finger, until there is a pocket between the eyelid and the eye. The drop will go in here (picture 2) Bring the bottle tip close to the eye. Use a mirror if it helps Do not touch the eye or eyelid, surrounding areas or other surfaces with the dropper. It could infect the drops Gently squeeze the bottle to release one drop of TRAVATAN at a time. (picture 3) After using TRAVATAN, keep the eyelid closed, apply gentle pressure by pressing a finger into the corner of the eye, by the nose (picture 4) for at least 1 minute. This helps to stop TRAVATAN getting into the rest of the body If you use drops in both eyes, repeat the steps for the other eye Close the bottle cap firmly immediately after use Only use one bottle at a time. Do not open the pouch until you need to use the bottle. If a drop misses the eye, try again. If you or your child are using other eye preparations such as eye drop or eye ointment, wait for at least 5 minutes between putting in TRAVATAN and the other eye preparations. If you or your child receive more TRAVATAN than you should Rinse all the medicine out with warm water. Don t put in any more drops until it s time for the next regular dose. If you forget to use TRAVATAN Continue with the next dose as planned. Do not use a double dose to make up for a forgotten dose. Never use more than one drop in the affected eye(s) in a single day. If you stop using TRAVATAN Do not stop using TRAVATAN without first speaking to your doctor or the doctor treating your child, the pressure in your eye or your child s eye will not be controlled which could lead to loss of sight. If you have any further questions on the use of this medicine, ask your doctor, the doctor treating your child or pharmacist. Now turn over 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. 3

You can usually carry on using the drops, unless the side effects are serious. If you re worried, talk to a doctor or pharmacist. Do not stop taking TRAVATAN without speaking to your doctor. The following side effects have been seen with TRAVATAN Very common side effects: may affect more than 1 in 10 people Effects in the eye: eye redness. Common side effects: may affect up to 1 in 10 people Effects in the eye: changes in the colour of the iris (coloured part of the eye), eye pain, eye discomfort, dry eye, itchy eye, eye irritation. Uncommon side effects: may affect up to 1 in 100 people Effects in the eye: corneal disorder, eye inflammation, iris inflammation, inflammation inside the eye, eye surface inflammation with/out surface damage, sensitivity to light, eye discharge, eyelid inflammation, eyelid redness, swelling around the eye, eyelid itching, blurred vision, increased tear production, infection or inflammation of the conjunctiva (conjunctivitis), abnormal turning outward of the lower eyelid, clouding of the eye, eyelid crusting, growth of eyelashes. General side effects: increased allergic symptoms, headache, irregular heart beat, cough, stuffy nose, throat irritation, darkening of skin around the eye (s), skin darkening, abnormal hair texture, excessive hair growth. Rare: may affect up to 1 in 1,000 people Effects in the eye: perception of flashing lights, eczema of the eyelids, abnormally positioned eyelashes that grow back toward the eye, eye swelling, reduced vision, halo vision, decreased eye sensation, inflammation of the glands of the eyelids, pigmentation inside the eye, increase in pupil size, eyelash thickening, change in eyelash colour, tired eyes. General side effects: eye viral infection, dizziness, bad taste, irregular or decreased heart rate, increased or decreased blood pressure, shortness of breath, asthma, nasal allergy or inflammation, nasal dryness, voice changes, gastrointestinal discomfort or ulcer, constipation, dry mouth, redness or itching of the skin, rash, hair colour change, loss of eyelashes, joint pain, musculoskeletal pain, generalised weakness. Not known: frequency cannot be estimated from the available data Effects in the eye: inflammation of the back of the eye, eyes appear more inset. General side effects: depression, anxiety, insomnia, sensation of false movement, ringing in ears, chest pain, abnormal heart rhythm, increased heart beat, worsening of asthma, diarrhea, nose bleeds, abdominal pain, nausea, vomiting, itching, abnormal hair growth, painful or involuntary urination, increase in prostate cancer marker. In children and adolescents, the most common side effects seen with TRAVATAN are eye redness and growth of eyelashes. Both side effects were observed with a higher incidence in children and adolescents compared to adults. Reporting of side effects 4

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system (see details below). By reporting side effects you can help provide more information on the safety of this medicine. United Kingdom Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard Ireland HPRA Pharmacovigilance Earlsfort Terrace IRL - Dublin 2 Tel: +353 1 6764971 Fax: +353 1 6762517 Website: www.hpra.ie e-mail: medsafety@hpra.ie Malta ADR Reporting Website: www.medicinesauthority.gov.mt/adrportal 5. How to store TRAVATAN Keep this medicine out of the sight and reach of children. Do not use TRAVATAN after the expiry date which is stated on the bottle and the box after Exp. The expiry date refers to the last day of the month. This medicine does not require any special storage conditions. You must throw away the bottle 4 weeks after you first opened it, to prevent infections, and use a new bottle. Write down the date you opened it in the space on the carton box. Do not throw away medicine via wastewater or in household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What TRAVATAN contains The active substance is travoprost 40 micrograms/ml. The other ingredients are:polyquaternium-1, polyoxyethylene hydrogenated castor oil 40, propylene glycol, sodium chloride, boric acid, mannitol and purified water. Tiny amounts of hydrochloric acid or sodium hydroxide are added to keep acidity levels (ph levels) normal. What TRAVATAN looks like and contents of the pack TRAVATAN is a liquid (a clear, colourless solution) supplied in a pack containing a 4 ml plastic bottle with a screw cap. Each bottle contains 2.5 ml of travoprost eye drops and each bottle is placed in a pouch. Pack sizes: 1 or 3 bottles. 5

Not all pack sizes may be marketed. The marketing authorisation holder Manufacturer Novartis Europharm Limited S.A. Alcon-Couvreur N.V. Frimley Business Park Rijksweg 14 Camberley GU16 7SR B-2870 Puurs United Kingdom. Belgium For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder. Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 United Kingdom Novartis Pharmaceuticals UK Ltd. Tel: +44 1276 698370 Malta Novartis Pharma Services Inc. Tel: +356 2122 2872 This leaflet was last revised in 04/2017 Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu. 6